HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A E Lang Selected Research

pardoprunox

5/2012Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial.
1/2009Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A E Lang Research Topics

Disease

35Parkinson Disease (Parkinson's Disease)
11/2015 - 01/2000
8Dyskinesias (Dyskinesia)
05/2012 - 01/2000
6Parkinsonian Disorders (Parkinsonism)
03/2009 - 04/2000
4Tremor (Tremors)
06/2014 - 03/2001
4Gambling (Pathological Gambling)
11/2010 - 06/2006
3Dementia (Dementias)
03/2009 - 06/2000
2Neoplasms (Cancer)
01/2017 - 12/2012
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2015 - 09/2014
2Tauopathies
09/2014 - 03/2009
2Movement Disorders (Movement Disorder)
12/2012 - 06/2005
2Pain (Aches)
05/2012 - 08/2004
2Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
02/2012 - 05/2009
2Torticollis (Wryneck)
02/2007 - 08/2004
2Myoclonic dystonia
07/2003 - 03/2000
2Psychotic Disorders (Schizoaffective Disorder)
07/2001 - 06/2001
2Dopa-responsive Dystonia
06/2000 - 04/2000
1Anthrax
01/2017
1Synucleinopathies
06/2015
1Conversion Disorder (Astasia Abasia)
04/2015
1Alzheimer Disease (Alzheimer's Disease)
09/2014
1Wounds and Injuries (Trauma)
12/2012
1Substance-Related Disorders (Drug Abuse)
11/2010
1Gaucher Disease (Gaucher's Disease)
10/2009
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2009
1Frontotemporal Dementia (Semantic Dementia)
03/2009
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
03/2009
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
03/2009
1Corticobasal Degeneration
03/2009
1Disorders of Excessive Somnolence (Hypersomnia)
11/2007
1Paroxysmal nonkinesigenic dyskinesia
05/2007
1Primary Cervical Dystonia
02/2007
1Hyperhomocysteinemia
06/2006
1Stroke (Strokes)
06/2006
1Heart Diseases (Heart Disease)
06/2006
1Essential Tremor (Essential Tremors)
06/2005
1Restless Legs Syndrome (Restless Legs)
12/2004
1Hyponatremia
01/2003
1Paresthesia (Dysesthesia)
01/2003
1Anorexia
01/2003
1Vomiting
01/2003
1Weight Loss (Weight Reduction)
01/2003
1Nausea
01/2003
1Hypokinesia (Bradykinesia)
10/2001
1Hallucinations (Hallucination)
07/2001
1Orthostatic Hypotension (Postural Hypotension)
05/2001
1Tics (Tic)
03/2001

Drug/Important Bio-Agent (IBA)

13Levodopa (L Dopa)FDA LinkGeneric
11/2015 - 04/2000
9Dopamine Agonists (Dopamine Agonist)IBA
11/2010 - 04/2000
4Pharmaceutical PreparationsIBA
11/2010 - 07/2001
3Dopamine Agents (Dopaminergic Agents)IBA
11/2007 - 04/2000
2pardoprunoxIBA
05/2012 - 01/2009
2Dopamine (Intropin)FDA LinkGeneric
05/2009 - 05/2000
2ropinirole (Requip)FDA LinkGeneric
11/2007 - 05/2000
2ApomorphineFDA Link
07/2001 - 04/2000
2GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
06/2000 - 04/2000
1ErbB Receptors (EGF Receptor)IBA
01/2017
1Adenosine Diphosphate (ADP)IBA
01/2017
1AntigensIBA
01/2017
1Epidermal Growth Factor (EGF)IBA
01/2017
1Bacterial ToxinsIBA
01/2017
1Immunotoxins (Immunotoxin)IBA
01/2017
1NeurturinIBA
06/2015
1Nerve Growth Factors (Neurotrophins)IBA
06/2015
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
09/2014
1Complement System Proteins (Complement)IBA
09/2014
1Amantadine (Aman)FDA LinkGeneric
02/2012
1amsonic acid (DAS)IBA
11/2010
1Glucosylceramidase (Glucocerebrosidase)IBA
10/2009
1RacloprideIBA
05/2009
1Biomarkers (Surrogate Marker)IBA
03/2009
1tau Proteins (tau Protein)IBA
03/2009
1Pramipexole (Mirapex)FDA LinkGeneric
11/2007
1Caffeine (No Doz)FDA LinkGeneric
05/2007
1VitaminsIBA
06/2006
1entacapone (Comtan)FDA Link
06/2006
1HomocysteineIBA
06/2006
1Phosphotransferases (Kinase)IBA
09/2005
1Leucine (L-Leucine)FDA Link
09/2005
1Sarcoglycans (beta Sarcoglycan)IBA
07/2003
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2003
1Lidocaine (Xylocaine)FDA LinkGeneric
10/2001
1MuscimolIBA
10/2001
1GABA-A Receptor AgonistsIBA
10/2001
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2001
1Glucose (Dextrose)FDA LinkGeneric
08/2001
1Apolipoproteins AIBA
07/2001
1Antipsychotic Agents (Antipsychotics)IBA
07/2001
1Amoxapine (Asendin)FDA Link
07/2001
1Olanzapine (Zyprexa)FDA Link
06/2001
1Domperidone (Domperidon)IBA
05/2001
1Botulinum Toxins (Botulinum Toxin)IBA
03/2001

Therapy/Procedure

13Deep Brain Stimulation
04/2008 - 01/2000
6Therapeutics
07/2012 - 04/2000
6Pallidotomy
12/2002 - 01/2000
4Transcranial Magnetic Stimulation
04/2015 - 03/2001
3Activities of Daily Living (ADL)
05/2012 - 01/2000
2Injections
01/2003 - 03/2001
1Patient Care
11/2015
1Physical Therapy Modalities (Physical Therapy Technique)
06/2014
1Palliative Care (Palliative Therapy)
12/2012